ABSCIENCES (EPA:AB) | WebDisclosure

BRIEF

published on 10/10/2024 at 08:32, 1 year 7 months ago

AB Science Reports Mid-2024 Financial Results and Clinical Developments

Financial Results Clinical Trials Capital Increase AB Science Masitinib
BRIEF

published on 10/10/2024 at 08:32, 1 year 7 months ago

AB Science publie ses résultats financiers et ses développements cliniques pour la mi-2024

Résultats Financiers Augmentation De Capital Essais Cliniques Masitinib Sciences AB
PRESS RELEASE

published on 10/10/2024 at 08:27, 1 year 7 months ago

AB Science: Revenues for the first half of 2024 and update on AB Science’s activities
AB Science presents financial results for the first half of 2024, updates on clinical development in ALS and MS, positive results in Covid-19 study, and intellectual property strengthening. AB announces capital increase and coverage initiations. Press Release by AB Science SA

Financial Results Capital Increase Clinical Development Intellectual Property AB Science
PRESS RELEASE

published on 10/10/2024 at 08:27, 1 year 7 months ago

AB Science : Résultats financiers semestriels au 30 juin 2024 et point sur les activités d’AB Science
AB Science présente ses résultats financiers au premier semestre 2024 et les événements clés de la période, incluant le développement du masitinib, les résultats positifs dans la Covid-19 et le renforcement de la propriété intellectuelle

Résultats Financiers COVID-19 Développement Clinique AB Science Masitinib
BRIEF

published on 09/30/2024 at 08:34, 1 year 7 months ago

AB Science annonce une augmentation de capital de 5,0 millions d’euros

Augmentation De Capital Développement Clinique AB Science Masitinib Investisseurs Européens
BRIEF

published on 09/30/2024 at 08:34, 1 year 7 months ago

AB Science announces a capital increase of 5.0 million euros

Capital Increase Clinical Development AB Science Masitinib European Investors
PRESS RELEASE

published on 09/30/2024 at 08:29, 1 year 7 months ago

AB Science annonce une augmentation de capital de 5,0 millions d’euros
AB Science annonce avec succès une augmentation de capital de 5 millions d’euros par placement privé pour financer le développement clinique de AB8939

Placement Privé Augmentation De Capital Développement Clinique AB Science AB8939
BRIEF

published on 09/23/2024 at 17:56, 1 year 7 months ago

AB Science fait le point sur le développement du masitinib dans les formes progressives de sclérose en plaques

Sclérose En Plaques Traitement Masitinib ECTRIMS 2024 Neurodégénératif
BRIEF

published on 09/23/2024 at 17:56, 1 year 7 months ago

AB Science provides an update on the development of masitinib in progressive forms of multiple sclerosis

Multiple Sclerosis Treatment Masitinib ECTRIMS 2024 Neurodegenerative
PRESS RELEASE

published on 09/23/2024 at 17:51, 1 year 7 months ago

AB Science fait aujourd'hui le point sur le développement du masitinib dans les formes progressives de la sclérose en plaques suite à la conférence ECTRIMS 2024
AB Science fait le point sur le développement du masitinib dans les formes progressives de la sclérose en plaques après la conférence ECTRIMS 2024

Sclérose En Plaques AB Science Masitinib ECTRIMS 2024 Étude MAXIMS

Published on 05/21/2026 at 15:00, 2 hours 45 minutes ago

Karbon-X Expands Global Energy Attribute Certificate Market Capabilities Amid Growing Renewable Procurement Demand
Published on 05/21/2026 at 14:30, 3 hours 15 minutes ago

Rio Grande Resources Advances District-Scale Gold-Silver Target Definition at its Winston Project Through Structural Mapping of Multiple Vein Corridor Systems
Published on 05/21/2026 at 14:00, 3 hours 45 minutes ago

Nextech3d.ai to Showcase AI Event Operating System and Krafty Labs Marketplace at Leading EMRG Media Event in New York
Published on 05/21/2026 at 14:00, 3 hours 45 minutes ago

Jade Leader Reviews Its Available Critical Minerals Assets
Published on 05/21/2026 at 14:00, 3 hours 45 minutes ago

Horizon Aircraft Advances Dual-Use Certification Path Through Cert Center Canada Partnership

View all ACCESSWIRE

Published on 05/21/2026 at 17:32, 13 minutes ago

EQS-Adhoc: hep global GmbH wins financial investor FH Capital to strengthen US business
Published on 05/21/2026 at 17:30, 15 minutes ago

Mutares completes successful exit of Terranor Group – High demand among institutional investors
Published on 05/21/2026 at 17:17, 28 minutes ago

In celebration of its 25th year on the stock market: init keeps reaching new record levels
Published on 05/21/2026 at 16:45, 1 hour ago

tonies SE - Invitation to Capital Markets Day 2026 (June 18, London)
Published on 05/21/2026 at 16:38, 1 hour 7 minutes ago

Groundbreaking Ceremony in Schafhöfen

View all EQS

Published on 05/21/2026 at 16:35, 1 hour 10 minutes ago

260521 BENETEAU Déclaration du nombre d'actions et de droits de vote au 30-04-2026
Published on 05/21/2026 at 07:30, 10 hours 15 minutes ago

Biophytis participe au premier Sommet de la Longévité
Published on 05/21/2026 at 07:30, 10 hours 15 minutes ago

Biophytis participates in the first Longevity Summit
Published on 05/20/2026 at 18:00, 23 hours 45 minutes ago

General shareholders meeting of 20 May, 2026
Published on 05/20/2026 at 18:00, 23 hours 45 minutes ago

General shareholders meeting of 20 May, 2026

View all LES ECHOS COMFI WIRE

News